Advanced Clinical Enhances Alzheimer's Patient Recruitment and Retention with Cognitive Clinical Trials (CCT)

Share Article

Advanced Clinical announced a new partnership with Cognitive Clinical Trials (CCT). This new partnership enables Advanced Clinical to expedite Alzheimer’s Disease research by improving patients’ access to trials, and enhancing Alzheimer’s patient recruitment and retention for sponsors.

Advanced Clinical partners with Cognitive Clinical Trials (CCT)

“As CCT’s only CRO partner, we are excited to offer our customers direct access to this patient population through our collaboration,” said Julie Ross, President of Advanced Clinical.

Advanced Clinical, a clinical development organization providing CRO, FSP, Strategic Resourcing and Consulting Services, today announced a new partnership with Cognitive Clinical Trials (CCT), a company that provides streamlined solutions to help sponsors, sites and patients overcome long-standing recruitment road blocks in Alzheimer’s clinical trials. This new partnership enables Advanced Clinical to expedite Alzheimer’s Disease research by improving patients’ access to trials, and enhancing Alzheimer’s patient recruitment and retention for sponsors.

CCT offers an innovative approach to conducting clinical research for the prevention and treatment of Alzheimer’s Disease. The company has created a new research model that overcomes the top obstacles facing this research category. CCT’s model brings clinical trials directly to patients who may otherwise be unable to participate due to concerns over travel, scheduling or health conditions. This is accomplished by embedding a clinical research infrastructure within established senior living communities. The infrastructure includes a clinic staffed by physicians, clinical research coordinators and other research professionals.

“As CCT’s only CRO partner, we are excited to offer our customers direct access to this patient population through our collaboration,” said Julie Ross, President of Advanced Clinical. “Our partnership further improves the critical communication pathway between Alzheimer’s patients, caregivers, sites and researchers, and drives improved quality and efficiencies in the conduct of clinical trials.”

There are currently more than five million Americans living with Alzheimer’s Disease. While there are treatments, there is no cure. Advanced Clinical is proud to partner with CCT in offering new hope in the fight against this debilitating disease.

About Cognitive Clinical Trials
Cognitive Clinical Trials (CCT) is a company offering an innovative approach to conducting clinical research for the prevention and treatment of Alzheimer’s Disease. CCT embeds research facilities in senior living communities, which simplifies the process for patients and provides sponsors with high quality data. For more information, visit http://www.cctresearch.com.

About Advanced Clinical
Advanced Clinical is a global clinical services organization that provides CRO, FSP, Strategic Resourcing, and Consulting Services, including Quality & Validation, for biopharmaceutical and medical device organizations. Our mission is to deliver a better clinical experience for our clients. To learn more, visit http://www.advancedclinical.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Lizzie Evans
Visit website